CDRH’s Shuren Calls For ‘Reset’ Of FDA Medtech Initiatives
Programs disrupted by COVID-19 would be restarted in 2021 to guide developers on clinical decision support software, produce safe OTC hearing aids
US FDA device center director Jeff Shuren wants to hit the reset button for initiatives delayed by agency’s responses to the coronavirus pandemic.
